Efficacy and Safety Clinical Trial of Intranasal AST-726 for the Prevention of Migraine

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2007
The purpose of this migraine prevention study is to evaluate the efficacy and safety of AST-726 in moderate to severe migraine patients at one of two doses compared to placebo and compared to a baseline period as measured by a reduction in the number of migraine days.
Epistemonikos ID: 0628e2c9b45215e7504cc95a43c0f541e661d2aa
First added on: May 04, 2024